News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
A leading doctor reveals 10 everyday foods that naturally mimic the effects of Ozempic. They can help curb cravings, boost ...
ATTENTION NYSE: NVO INVESTORS: Contact Berger Montague About a Novo Nordisk A/S Class Action Lawsuit
Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, ...
If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...
A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...
9h
Medpage Today on MSNGLP-1 Maker Accused of Bribing Docs; FDA Warns on Unapproved Meds; PFAS in Devices
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...
And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry Dimbleby, a food campaigner and founder of Leon, called Ozempic “the ...
The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...
The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results have been mostly positive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results